NDAT.CN Stock Surges 69% on CNQ Exchange in April 2026

NDAT.CN stock has delivered a 69.23% gain in recent trading, pushing the share price to C$0.11 on the CNQ exchange. nDatalyze Corp., a Calgary-based healthcare technology company, operates in the Medical – Healthcare Information Services sector. The company develops machine-learning mental health applications, database licensing solutions, and equipment for essential oil extraction serving medical cannabis growers. With a market cap of C$3.7 million and 41.3 million shares outstanding, NDAT.CN remains a micro-cap play. Trading volume reached 20,000 shares against an average of 23,405, signaling moderate investor interest. We’ll examine what’s driving this sharp price movement and what the fundamentals reveal about nDatalyze’s position.

NDAT.CN Stock Performance and Price Action

NDAT.CN stock has experienced dramatic volatility over multiple timeframes. The stock jumped 69.23% from a previous close of C$0.065 to C$0.11, marking a C$0.045 gain in a single session. Over the past year, NDAT.CN has climbed 350%, while the six-month return stands at 500%. However, the year-to-date performance also reflects a 500% gain, suggesting most of the rally occurred recently.

The 52-week range shows the stock trading between C$0.015 (low) and C$0.20 (high), indicating extreme price swings typical of micro-cap healthcare stocks. The 50-day moving average sits at C$0.0722, while the 200-day average is C$0.0301, suggesting the stock is trading well above longer-term support levels. This positioning indicates strong short-term momentum but raises questions about sustainability. Track NDAT.CN on Meyka for real-time updates on price movements and technical shifts.

Meyka AI Grade and Fundamental Analysis

Meyka AI rates NDAT.CN with a grade of C+, reflecting a “Hold” recommendation based on a score of 58.95 out of 100. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests caution despite recent price strength.

The fundamentals paint a challenging picture. NDAT.CN shows negative earnings per share (EPS) of -C$0.02 and a negative PE ratio of -4.5, indicating the company is unprofitable. Return on equity (ROE) stands at -34.06%, while return on assets (ROA) is -35.34%, both deeply negative. The current ratio of 21.6 is exceptionally high, suggesting strong liquidity, but this masks operational losses. Book value per share is C$0.0121, making the stock trade at 7.4 times book value—a premium for a loss-making micro-cap. These grades are not guaranteed and we are not financial advisors.

Market Sentiment and Trading Activity

Trading activity in NDAT.CN reflects mixed sentiment despite the price surge. Volume reached 20,000 shares, representing a relative volume of 2.01 compared to the 90-day average. This indicates above-average trading interest but not exceptional liquidity for a micro-cap stock.

The Money Flow Index (MFI) stands at 59.77, suggesting moderate buying pressure without extreme overbought conditions. The Relative Strength Index (RSI) is 53.14, indicating neutral momentum—neither overbought nor oversold. The Stochastic oscillator shows %K at 47.62 and %D at 36.51, suggesting the stock is in mid-range territory. The Average True Range (ATR) of C$0.01 reflects the typical daily price movement. These technical indicators suggest the recent rally may have room to run, but confirmation from volume and broader market conditions remains critical for sustained upside.

Liquidation Risk and Cash Position

NDAT.CN’s cash position provides a critical buffer against liquidation risk. The company holds C$0.0121 per share in cash, translating to roughly C$500,000 in total cash based on shares outstanding. With a market cap of only C$3.7 million, the cash-to-market-cap ratio is meaningful, though the company burns cash through operations.

Operating cash flow per share is -C$0.0035, indicating negative cash burn. Free cash flow mirrors this at -C$0.0035 per share. At this burn rate, the company has limited runway without revenue growth or capital raises. The debt-to-equity ratio is 0.0, meaning no debt burden, which is positive. However, the lack of revenue (revenue per share is C$0.00) and persistent losses create existential pressure. Investors should monitor quarterly cash burn rates and any announcements regarding financing or revenue milestones closely.

Final Thoughts

NDAT.CN’s 69% surge reflects speculation rather than fundamental strength. The healthcare technology company has strategic potential in AI mental health and equipment manufacturing, but faces significant risks: negative earnings, negative cash flow, and zero revenue. With a C+ grade and Hold recommendation, the stock remains high-risk and speculative. Strong liquidity and recent momentum may attract traders, but investors should require clear revenue traction and a profitability path before investing. The price surge appears to be a trading opportunity, not a fundamental turning point.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.